Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
6,982
archived clinical trials in
Endocrine

A Clinical Trial to Evaluate the Efficacy and Safety of Testosterone Gel in Adult Hypogonadal Males
A Phase 3, Open-Label, Non-Randomized, Clinical Trial to Evaluate the Efficacy and Safety of FE 999303 (Testosterone Gel) in Adult Hypogonadal Males
Status: Enrolling
Updated:  9/25/2017
Clinical Research Facility
mi
from
Purchase, NY
A Clinical Trial to Evaluate the Efficacy and Safety of Testosterone Gel in Adult Hypogonadal Males
A Phase 3, Open-Label, Non-Randomized, Clinical Trial to Evaluate the Efficacy and Safety of FE 999303 (Testosterone Gel) in Adult Hypogonadal Males
Status: Enrolling
Updated: 9/25/2017
Clinical Research Facility
mi
from
Purchase, NY
Click here to add this to my saved trials
A Clinical Trial to Evaluate the Efficacy and Safety of Testosterone Gel in Adult Hypogonadal Males
A Phase 3, Open-Label, Non-Randomized, Clinical Trial to Evaluate the Efficacy and Safety of FE 999303 (Testosterone Gel) in Adult Hypogonadal Males
Status: Enrolling
Updated:  9/25/2017
Clinical Research Facility
mi
from
Warwick, RI
A Clinical Trial to Evaluate the Efficacy and Safety of Testosterone Gel in Adult Hypogonadal Males
A Phase 3, Open-Label, Non-Randomized, Clinical Trial to Evaluate the Efficacy and Safety of FE 999303 (Testosterone Gel) in Adult Hypogonadal Males
Status: Enrolling
Updated: 9/25/2017
Clinical Research Facility
mi
from
Warwick, RI
Click here to add this to my saved trials
A Clinical Trial to Evaluate the Efficacy and Safety of Testosterone Gel in Adult Hypogonadal Males
A Phase 3, Open-Label, Non-Randomized, Clinical Trial to Evaluate the Efficacy and Safety of FE 999303 (Testosterone Gel) in Adult Hypogonadal Males
Status: Enrolling
Updated:  9/25/2017
Clinical Research Facility
mi
from
Nashville, TN
A Clinical Trial to Evaluate the Efficacy and Safety of Testosterone Gel in Adult Hypogonadal Males
A Phase 3, Open-Label, Non-Randomized, Clinical Trial to Evaluate the Efficacy and Safety of FE 999303 (Testosterone Gel) in Adult Hypogonadal Males
Status: Enrolling
Updated: 9/25/2017
Clinical Research Facility
mi
from
Nashville, TN
Click here to add this to my saved trials
A Clinical Trial to Evaluate the Efficacy and Safety of Testosterone Gel in Adult Hypogonadal Males
A Phase 3, Open-Label, Non-Randomized, Clinical Trial to Evaluate the Efficacy and Safety of FE 999303 (Testosterone Gel) in Adult Hypogonadal Males
Status: Enrolling
Updated:  9/25/2017
Clinical Research Facility
mi
from
Webster, TX
A Clinical Trial to Evaluate the Efficacy and Safety of Testosterone Gel in Adult Hypogonadal Males
A Phase 3, Open-Label, Non-Randomized, Clinical Trial to Evaluate the Efficacy and Safety of FE 999303 (Testosterone Gel) in Adult Hypogonadal Males
Status: Enrolling
Updated: 9/25/2017
Clinical Research Facility
mi
from
Webster, TX
Click here to add this to my saved trials
A Clinical Trial to Evaluate the Efficacy and Safety of Testosterone Gel in Adult Hypogonadal Males
A Phase 3, Open-Label, Non-Randomized, Clinical Trial to Evaluate the Efficacy and Safety of FE 999303 (Testosterone Gel) in Adult Hypogonadal Males
Status: Enrolling
Updated:  9/25/2017
Clinical Research Facility
mi
from
Norfolk, VA
A Clinical Trial to Evaluate the Efficacy and Safety of Testosterone Gel in Adult Hypogonadal Males
A Phase 3, Open-Label, Non-Randomized, Clinical Trial to Evaluate the Efficacy and Safety of FE 999303 (Testosterone Gel) in Adult Hypogonadal Males
Status: Enrolling
Updated: 9/25/2017
Clinical Research Facility
mi
from
Norfolk, VA
Click here to add this to my saved trials
A Clinical Trial to Evaluate the Efficacy and Safety of Testosterone Gel in Adult Hypogonadal Males
A Phase 3, Open-Label, Non-Randomized, Clinical Trial to Evaluate the Efficacy and Safety of FE 999303 (Testosterone Gel) in Adult Hypogonadal Males
Status: Enrolling
Updated:  9/25/2017
Clinical Research Facility
mi
from
Garden City, NY
A Clinical Trial to Evaluate the Efficacy and Safety of Testosterone Gel in Adult Hypogonadal Males
A Phase 3, Open-Label, Non-Randomized, Clinical Trial to Evaluate the Efficacy and Safety of FE 999303 (Testosterone Gel) in Adult Hypogonadal Males
Status: Enrolling
Updated: 9/25/2017
Clinical Research Facility
mi
from
Garden City, NY
Click here to add this to my saved trials
A Clinical Trial to Evaluate the Efficacy and Safety of Testosterone Gel in Adult Hypogonadal Males
A Phase 3, Open-Label, Non-Randomized, Clinical Trial to Evaluate the Efficacy and Safety of FE 999303 (Testosterone Gel) in Adult Hypogonadal Males
Status: Enrolling
Updated:  9/25/2017
mi
from
Bala-Cynwyd, PA
A Clinical Trial to Evaluate the Efficacy and Safety of Testosterone Gel in Adult Hypogonadal Males
A Phase 3, Open-Label, Non-Randomized, Clinical Trial to Evaluate the Efficacy and Safety of FE 999303 (Testosterone Gel) in Adult Hypogonadal Males
Status: Enrolling
Updated: 9/25/2017
mi
from
Bala-Cynwyd, PA
Click here to add this to my saved trials
A Clinical Trial to Evaluate the Efficacy and Safety of Testosterone Gel in Adult Hypogonadal Males
A Phase 3, Open-Label, Non-Randomized, Clinical Trial to Evaluate the Efficacy and Safety of FE 999303 (Testosterone Gel) in Adult Hypogonadal Males
Status: Enrolling
Updated:  9/25/2017
Clinical Research Facility
mi
from
Mount Pleasant, SC
A Clinical Trial to Evaluate the Efficacy and Safety of Testosterone Gel in Adult Hypogonadal Males
A Phase 3, Open-Label, Non-Randomized, Clinical Trial to Evaluate the Efficacy and Safety of FE 999303 (Testosterone Gel) in Adult Hypogonadal Males
Status: Enrolling
Updated: 9/25/2017
Clinical Research Facility
mi
from
Mount Pleasant, SC
Click here to add this to my saved trials
Slowing HEART diSease With Lifestyle and Omega-3 Fatty Acids
Slowing HEART diSease With Lifestyle and Omega-3 Fatty Acids (HEARTS)
Status: Enrolling
Updated:  9/26/2017
Beth Israel Deaconess Medical Center
mi
from
Boston, MA
Slowing HEART diSease With Lifestyle and Omega-3 Fatty Acids
Slowing HEART diSease With Lifestyle and Omega-3 Fatty Acids (HEARTS)
Status: Enrolling
Updated: 9/26/2017
Beth Israel Deaconess Medical Center
mi
from
Boston, MA
Click here to add this to my saved trials
Slowing HEART diSease With Lifestyle and Omega-3 Fatty Acids
Slowing HEART diSease With Lifestyle and Omega-3 Fatty Acids (HEARTS)
Status: Enrolling
Updated:  9/26/2017
South Shore Medical Group
mi
from
Milton, MA
Slowing HEART diSease With Lifestyle and Omega-3 Fatty Acids
Slowing HEART diSease With Lifestyle and Omega-3 Fatty Acids (HEARTS)
Status: Enrolling
Updated: 9/26/2017
South Shore Medical Group
mi
from
Milton, MA
Click here to add this to my saved trials
Pioglitazone in Thyroid Cancers
Phase 2 Study of Pioglitazone in Thyroid Cancers That Contain the PAX8-PPARgamma Fusion Gene
Status: Enrolling
Updated:  9/27/2017
University of Colorado
mi
from
Aurora, CO
Pioglitazone in Thyroid Cancers
Phase 2 Study of Pioglitazone in Thyroid Cancers That Contain the PAX8-PPARgamma Fusion Gene
Status: Enrolling
Updated: 9/27/2017
University of Colorado
mi
from
Aurora, CO
Click here to add this to my saved trials
Pioglitazone in Thyroid Cancers
Phase 2 Study of Pioglitazone in Thyroid Cancers That Contain the PAX8-PPARgamma Fusion Gene
Status: Enrolling
Updated:  9/27/2017
University of Michigan
mi
from
Ann Arbor, MI
Pioglitazone in Thyroid Cancers
Phase 2 Study of Pioglitazone in Thyroid Cancers That Contain the PAX8-PPARgamma Fusion Gene
Status: Enrolling
Updated: 9/27/2017
University of Michigan
mi
from
Ann Arbor, MI
Click here to add this to my saved trials
Pioglitazone in Thyroid Cancers
Phase 2 Study of Pioglitazone in Thyroid Cancers That Contain the PAX8-PPARgamma Fusion Gene
Status: Enrolling
Updated:  9/27/2017
Univ of Pennsylvania
mi
from
Philadelphia, PA
Pioglitazone in Thyroid Cancers
Phase 2 Study of Pioglitazone in Thyroid Cancers That Contain the PAX8-PPARgamma Fusion Gene
Status: Enrolling
Updated: 9/27/2017
Univ of Pennsylvania
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Pioglitazone in Thyroid Cancers
Phase 2 Study of Pioglitazone in Thyroid Cancers That Contain the PAX8-PPARgamma Fusion Gene
Status: Enrolling
Updated:  9/27/2017
University of Texas M.D. Anderson Cancer Center
mi
from
Houston, TX
Pioglitazone in Thyroid Cancers
Phase 2 Study of Pioglitazone in Thyroid Cancers That Contain the PAX8-PPARgamma Fusion Gene
Status: Enrolling
Updated: 9/27/2017
University of Texas M.D. Anderson Cancer Center
mi
from
Houston, TX
Click here to add this to my saved trials
Comparison of Neutral Protamine Hagedorn (NPH) and Lantus Based Insulin Regimen in the Management of Hypoglycemia in the Hospitalized Patients in Noncritical Care Setting
Comparison of Neutral Protamine Hagedorn (NPH) and Lantus Based Insulin Regimen in the Management of Hypoglycemia in the Hospitalized Patients in Noncritical Care Setting
Status: Enrolling
Updated:  9/27/2017
Riverside County Regional Medical Center
mi
from
Moreno Valley, CA
Comparison of Neutral Protamine Hagedorn (NPH) and Lantus Based Insulin Regimen in the Management of Hypoglycemia in the Hospitalized Patients in Noncritical Care Setting
Comparison of Neutral Protamine Hagedorn (NPH) and Lantus Based Insulin Regimen in the Management of Hypoglycemia in the Hospitalized Patients in Noncritical Care Setting
Status: Enrolling
Updated: 9/27/2017
Riverside County Regional Medical Center
mi
from
Moreno Valley, CA
Click here to add this to my saved trials
Effects of Growth Hormone Releasing Hormone in HIV
Effects of Growth Hormone Releasing Hormone on Fat Redistribution, Cardiovascular Indices, and Growth Hormone Secretion in HIV Lipodystrophy
Status: Enrolling
Updated:  9/28/2017
Massachusetts General Hospital
mi
from
Boston, MA
Effects of Growth Hormone Releasing Hormone in HIV
Effects of Growth Hormone Releasing Hormone on Fat Redistribution, Cardiovascular Indices, and Growth Hormone Secretion in HIV Lipodystrophy
Status: Enrolling
Updated: 9/28/2017
Massachusetts General Hospital
mi
from
Boston, MA
Click here to add this to my saved trials
The Health Effects of Blueberry Anthocyanins in Metabolic Syndrome (the CIRCLES-study)
The Effects of Blueberry Anthocyanins on Insulin Resistance and Vascular, Lung and Cognitive Function in a Population With Metabolic Syndrome.
Status: Enrolling
Updated:  9/28/2017
Harvard School of Public Health
mi
from
Boston, MA
The Health Effects of Blueberry Anthocyanins in Metabolic Syndrome (the CIRCLES-study)
The Effects of Blueberry Anthocyanins on Insulin Resistance and Vascular, Lung and Cognitive Function in a Population With Metabolic Syndrome.
Status: Enrolling
Updated: 9/28/2017
Harvard School of Public Health
mi
from
Boston, MA
Click here to add this to my saved trials
The Health Effects of Blueberry Anthocyanins in Metabolic Syndrome (the CIRCLES-study)
The Effects of Blueberry Anthocyanins on Insulin Resistance and Vascular, Lung and Cognitive Function in a Population With Metabolic Syndrome.
Status: Enrolling
Updated:  9/28/2017
Addenbrooke's hospital
mi
from
Cambridge,
The Health Effects of Blueberry Anthocyanins in Metabolic Syndrome (the CIRCLES-study)
The Effects of Blueberry Anthocyanins on Insulin Resistance and Vascular, Lung and Cognitive Function in a Population With Metabolic Syndrome.
Status: Enrolling
Updated: 9/28/2017
Addenbrooke's hospital
mi
from
Cambridge,
Click here to add this to my saved trials
Prospective Study of Undiagnosed Celiac Disease
Epidemiology of Celiac Disease: A Prospective Study of Undiagnosed Celiac Disease in the Community
Status: Enrolling
Updated:  9/28/2017
Mayo Clinic Rochester
mi
from
Rochester, MN
Prospective Study of Undiagnosed Celiac Disease
Epidemiology of Celiac Disease: A Prospective Study of Undiagnosed Celiac Disease in the Community
Status: Enrolling
Updated: 9/28/2017
Mayo Clinic Rochester
mi
from
Rochester, MN
Click here to add this to my saved trials
Testosterone Replacement Therapy in Chronic Spinal Cord Injury
Testosterone Replacement Therapy in Chronic Spinal Cord Injury
Status: Enrolling
Updated:  9/29/2017
Kessler Institute for Rehabilitation
mi
from
West Orange, NJ
Testosterone Replacement Therapy in Chronic Spinal Cord Injury
Testosterone Replacement Therapy in Chronic Spinal Cord Injury
Status: Enrolling
Updated: 9/29/2017
Kessler Institute for Rehabilitation
mi
from
West Orange, NJ
Click here to add this to my saved trials
Testosterone Replacement Therapy in Chronic Spinal Cord Injury
Testosterone Replacement Therapy in Chronic Spinal Cord Injury
Status: Enrolling
Updated:  9/29/2017
James J. Peters VA Medical Center
mi
from
The Bronx, NY
Testosterone Replacement Therapy in Chronic Spinal Cord Injury
Testosterone Replacement Therapy in Chronic Spinal Cord Injury
Status: Enrolling
Updated: 9/29/2017
James J. Peters VA Medical Center
mi
from
The Bronx, NY
Click here to add this to my saved trials
A Pilot Study of Rituximab for the Anticoagulation Resistant Manifestations of Antiphospholipid Syndrome
A Pilot Study of Rituximab for the Anticoagulation Resistant Manifestations of Antiphospholipid Syndrome (RITAPS)
Status: Enrolling
Updated:  10/2/2017
Barbara Volcker Center for Women and Rheumatic Disease, Hospital for Special Surgery
mi
from
New York, NY
A Pilot Study of Rituximab for the Anticoagulation Resistant Manifestations of Antiphospholipid Syndrome
A Pilot Study of Rituximab for the Anticoagulation Resistant Manifestations of Antiphospholipid Syndrome (RITAPS)
Status: Enrolling
Updated: 10/2/2017
Barbara Volcker Center for Women and Rheumatic Disease, Hospital for Special Surgery
mi
from
New York, NY
Click here to add this to my saved trials
The VA Diabetes Trial Follow-up Study (VADT-FS)
CSP #465FS - VA Diabetes Trial Long Term Follow-up Study
Status: Enrolling
Updated:  10/2/2017
Phoenix VA Health Care System, Phoenix, AZ
mi
from
Phoenix, AZ
The VA Diabetes Trial Follow-up Study (VADT-FS)
CSP #465FS - VA Diabetes Trial Long Term Follow-up Study
Status: Enrolling
Updated: 10/2/2017
Phoenix VA Health Care System, Phoenix, AZ
mi
from
Phoenix, AZ
Click here to add this to my saved trials
The VA Diabetes Trial Follow-up Study (VADT-FS)
CSP #465FS - VA Diabetes Trial Long Term Follow-up Study
Status: Enrolling
Updated:  10/2/2017
Miami VA Healthcare System, Miami, FL
mi
from
Miami, FL
The VA Diabetes Trial Follow-up Study (VADT-FS)
CSP #465FS - VA Diabetes Trial Long Term Follow-up Study
Status: Enrolling
Updated: 10/2/2017
Miami VA Healthcare System, Miami, FL
mi
from
Miami, FL
Click here to add this to my saved trials
Etanercept in Kawasaki Disease
A Randomized, Double Blind, Placebo Controlled Study of the Effects of Etanercept in Children Presenting With Kawasaki Disease
Status: Enrolling
Updated:  10/3/2017
Feinstein Institute for Medical Rsearch
mi
from
New Hyde Park, NY
Etanercept in Kawasaki Disease
A Randomized, Double Blind, Placebo Controlled Study of the Effects of Etanercept in Children Presenting With Kawasaki Disease
Status: Enrolling
Updated: 10/3/2017
Feinstein Institute for Medical Rsearch
mi
from
New Hyde Park, NY
Click here to add this to my saved trials
Etanercept in Kawasaki Disease
A Randomized, Double Blind, Placebo Controlled Study of the Effects of Etanercept in Children Presenting With Kawasaki Disease
Status: Enrolling
Updated:  10/3/2017
Columbia University Medical Center
mi
from
New York, NY
Etanercept in Kawasaki Disease
A Randomized, Double Blind, Placebo Controlled Study of the Effects of Etanercept in Children Presenting With Kawasaki Disease
Status: Enrolling
Updated: 10/3/2017
Columbia University Medical Center
mi
from
New York, NY
Click here to add this to my saved trials
Etanercept in Kawasaki Disease
A Randomized, Double Blind, Placebo Controlled Study of the Effects of Etanercept in Children Presenting With Kawasaki Disease
Status: Enrolling
Updated:  10/3/2017
Texas Children's Hospital
mi
from
Houston, TX
Etanercept in Kawasaki Disease
A Randomized, Double Blind, Placebo Controlled Study of the Effects of Etanercept in Children Presenting With Kawasaki Disease
Status: Enrolling
Updated: 10/3/2017
Texas Children's Hospital
mi
from
Houston, TX
Click here to add this to my saved trials
Etanercept in Kawasaki Disease
A Randomized, Double Blind, Placebo Controlled Study of the Effects of Etanercept in Children Presenting With Kawasaki Disease
Status: Enrolling
Updated:  10/3/2017
Primary Children's Medical Center
mi
from
Salt Lake City, UT
Etanercept in Kawasaki Disease
A Randomized, Double Blind, Placebo Controlled Study of the Effects of Etanercept in Children Presenting With Kawasaki Disease
Status: Enrolling
Updated: 10/3/2017
Primary Children's Medical Center
mi
from
Salt Lake City, UT
Click here to add this to my saved trials
Etanercept in Kawasaki Disease
A Randomized, Double Blind, Placebo Controlled Study of the Effects of Etanercept in Children Presenting With Kawasaki Disease
Status: Enrolling
Updated:  10/3/2017
Seattle Children's Hospital
mi
from
Seattle, WA
Etanercept in Kawasaki Disease
A Randomized, Double Blind, Placebo Controlled Study of the Effects of Etanercept in Children Presenting With Kawasaki Disease
Status: Enrolling
Updated: 10/3/2017
Seattle Children's Hospital
mi
from
Seattle, WA
Click here to add this to my saved trials
Etanercept in Kawasaki Disease
A Randomized, Double Blind, Placebo Controlled Study of the Effects of Etanercept in Children Presenting With Kawasaki Disease
Status: Enrolling
Updated:  10/3/2017
Children's Hospital of Wisconsin
mi
from
Milwaukee, WI
Etanercept in Kawasaki Disease
A Randomized, Double Blind, Placebo Controlled Study of the Effects of Etanercept in Children Presenting With Kawasaki Disease
Status: Enrolling
Updated: 10/3/2017
Children's Hospital of Wisconsin
mi
from
Milwaukee, WI
Click here to add this to my saved trials
Etanercept in Kawasaki Disease
A Randomized, Double Blind, Placebo Controlled Study of the Effects of Etanercept in Children Presenting With Kawasaki Disease
Status: Enrolling
Updated:  10/3/2017
Sainte-Justine Hospital
mi
from
Montreal,
Etanercept in Kawasaki Disease
A Randomized, Double Blind, Placebo Controlled Study of the Effects of Etanercept in Children Presenting With Kawasaki Disease
Status: Enrolling
Updated: 10/3/2017
Sainte-Justine Hospital
mi
from
Montreal,
Click here to add this to my saved trials
Etanercept in Kawasaki Disease
A Randomized, Double Blind, Placebo Controlled Study of the Effects of Etanercept in Children Presenting With Kawasaki Disease
Status: Enrolling
Updated:  10/3/2017
Montefiore Medical Center
mi
from
The Bronx, NY
Etanercept in Kawasaki Disease
A Randomized, Double Blind, Placebo Controlled Study of the Effects of Etanercept in Children Presenting With Kawasaki Disease
Status: Enrolling
Updated: 10/3/2017
Montefiore Medical Center
mi
from
The Bronx, NY
Click here to add this to my saved trials
Insulin Resistance in Patients With Major Depression
Insulin Resistance in Patients With Major Depression
Status: Enrolling
Updated:  10/3/2017
Stanford University School of Medicine
mi
from
Stanford, CA
Insulin Resistance in Patients With Major Depression
Insulin Resistance in Patients With Major Depression
Status: Enrolling
Updated: 10/3/2017
Stanford University School of Medicine
mi
from
Stanford, CA
Click here to add this to my saved trials
Pharmacology of Exenatide in Pediatric Sepsis
Phase 1-2 Study of the Pharmacology of Exenatide in Pediatric Sepsis
Status: Enrolling
Updated:  10/3/2017
Seattle Children's Hospital
mi
from
Seattle, WA
Pharmacology of Exenatide in Pediatric Sepsis
Phase 1-2 Study of the Pharmacology of Exenatide in Pediatric Sepsis
Status: Enrolling
Updated: 10/3/2017
Seattle Children's Hospital
mi
from
Seattle, WA
Click here to add this to my saved trials
Effects of Tumor Necrosis Factor (TNF)-Alpha Antagonism in Patients With Metabolic Syndrome
Effects of Tumor Necrosis Factor (TNF)-Alpha Antagonism in Patients With Metabolic Syndrome
Status: Enrolling
Updated:  10/4/2017
Mass General Hospital
mi
from
Boston, MA
Effects of Tumor Necrosis Factor (TNF)-Alpha Antagonism in Patients With Metabolic Syndrome
Effects of Tumor Necrosis Factor (TNF)-Alpha Antagonism in Patients With Metabolic Syndrome
Status: Enrolling
Updated: 10/4/2017
Mass General Hospital
mi
from
Boston, MA
Click here to add this to my saved trials
Ovarian Follicle Function in Patients With Primary Ovarian Failure
Ovarian Follicle Function in Patients With Primary Ovarian Insufficiency
Status: Enrolling
Updated:  10/5/2017
National Institutes of Health Clinical Center, 9000 Rockville Pike
mi
from
Bethesda, MD
Ovarian Follicle Function in Patients With Primary Ovarian Failure
Ovarian Follicle Function in Patients With Primary Ovarian Insufficiency
Status: Enrolling
Updated: 10/5/2017
National Institutes of Health Clinical Center, 9000 Rockville Pike
mi
from
Bethesda, MD
Click here to add this to my saved trials
Endocrine Studies in Health and Disease
Endocrine Studies in Health and Disease
Status: Enrolling
Updated:  10/5/2017
National Institutes of Health Clinical Center, 9000 Rockville Pike
mi
from
Bethesda, MD
Endocrine Studies in Health and Disease
Endocrine Studies in Health and Disease
Status: Enrolling
Updated: 10/5/2017
National Institutes of Health Clinical Center, 9000 Rockville Pike
mi
from
Bethesda, MD
Click here to add this to my saved trials
Studies of Children With Metabolic and Other Genetic Disorders
Studies of Pediatric Patients With Metabolic or Other Genetic Disorders
Status: Enrolling
Updated:  10/5/2017
National Institutes of Health Clinical Center, 9000 Rockville Pike
mi
from
Bethesda, MD
Studies of Children With Metabolic and Other Genetic Disorders
Studies of Pediatric Patients With Metabolic or Other Genetic Disorders
Status: Enrolling
Updated: 10/5/2017
National Institutes of Health Clinical Center, 9000 Rockville Pike
mi
from
Bethesda, MD
Click here to add this to my saved trials
Pharmacogenomic Response to Thyrotropin-Releasing Hormone Stimulation in Healthy Volunteers: The Influence of a Common Type 2 Deiodinase Genetic Polymorphism on Serum T3
Pharmacogenomic Response to Thyrotropin-Releasing Hormone Stimulation in Healthy Volunteers:The Influence of a Common Type 2 Deiodinase Genetic Polymorphism on Serum T3
Status: Enrolling
Updated:  10/5/2017
National Institutes of Health Clinical Center, 9000 Rockville Pike
mi
from
Bethesda, MD
Pharmacogenomic Response to Thyrotropin-Releasing Hormone Stimulation in Healthy Volunteers: The Influence of a Common Type 2 Deiodinase Genetic Polymorphism on Serum T3
Pharmacogenomic Response to Thyrotropin-Releasing Hormone Stimulation in Healthy Volunteers:The Influence of a Common Type 2 Deiodinase Genetic Polymorphism on Serum T3
Status: Enrolling
Updated: 10/5/2017
National Institutes of Health Clinical Center, 9000 Rockville Pike
mi
from
Bethesda, MD
Click here to add this to my saved trials
Radioactive Iodide Therapy for Pediatric Graves' Disease
Radioactive Iodide Therapy for Pediatric Graves' Disease
Status: Enrolling
Updated:  10/5/2017
University of Florida
mi
from
Gainesville, FL
Radioactive Iodide Therapy for Pediatric Graves' Disease
Radioactive Iodide Therapy for Pediatric Graves' Disease
Status: Enrolling
Updated: 10/5/2017
University of Florida
mi
from
Gainesville, FL
Click here to add this to my saved trials
Radioactive Iodide Therapy for Pediatric Graves' Disease
Radioactive Iodide Therapy for Pediatric Graves' Disease
Status: Enrolling
Updated:  10/5/2017
Texas Children's Hospital
mi
from
Houston, TX
Radioactive Iodide Therapy for Pediatric Graves' Disease
Radioactive Iodide Therapy for Pediatric Graves' Disease
Status: Enrolling
Updated: 10/5/2017
Texas Children's Hospital
mi
from
Houston, TX
Click here to add this to my saved trials
Rituximab for Autoimmune Retinopathy
Rituximab for Autoimmune Retinopathy
Status: Enrolling
Updated:  10/5/2017
National Institutes of Health Clinical Center, 9000 Rockville Pike
mi
from
Bethesda, MD
Rituximab for Autoimmune Retinopathy
Rituximab for Autoimmune Retinopathy
Status: Enrolling
Updated: 10/5/2017
National Institutes of Health Clinical Center, 9000 Rockville Pike
mi
from
Bethesda, MD
Click here to add this to my saved trials
Jugular Vein Sampling for Hormone Levels for the Diagnosis of Cushing Syndrome
Internal Jugular Vein Sampling for ACTH Levels for the Differential Diagnosis of Cushing Syndrome
Status: Enrolling
Updated:  10/5/2017
National Institutes of Health Clinical Center, 9000 Rockville Pike
mi
from
Bethesda, MD
Jugular Vein Sampling for Hormone Levels for the Diagnosis of Cushing Syndrome
Internal Jugular Vein Sampling for ACTH Levels for the Differential Diagnosis of Cushing Syndrome
Status: Enrolling
Updated: 10/5/2017
National Institutes of Health Clinical Center, 9000 Rockville Pike
mi
from
Bethesda, MD
Click here to add this to my saved trials
Targeted Levothyroxine Dosing in Infants With Congenital Hypothyroidism
Targeted Levothyroxine Dosing in Infants With Congenital Hypothyroidism
Status: Enrolling
Updated:  10/6/2017
Riley Hospital for Children
mi
from
Indianapolis, IN
Targeted Levothyroxine Dosing in Infants With Congenital Hypothyroidism
Targeted Levothyroxine Dosing in Infants With Congenital Hypothyroidism
Status: Enrolling
Updated: 10/6/2017
Riley Hospital for Children
mi
from
Indianapolis, IN
Click here to add this to my saved trials
Versartis Long-Acting Growth Hormone in Children Compared to Daily rhGH
Comparison of Somavaratan (VRS-317), a Long-acting Human Growth Hormone, to Daily rhGH in a Phase 3, Randomized, One-year, Open-label, Multi-center, Non-inferiority Trial in Pre-pubertal Children With Growth Hormone Deficiency.
Status: Enrolling
Updated:  10/11/2017
Pediatric Endocrinology of Phoenix
mi
from
Phoenix, AZ
Versartis Long-Acting Growth Hormone in Children Compared to Daily rhGH
Comparison of Somavaratan (VRS-317), a Long-acting Human Growth Hormone, to Daily rhGH in a Phase 3, Randomized, One-year, Open-label, Multi-center, Non-inferiority Trial in Pre-pubertal Children With Growth Hormone Deficiency.
Status: Enrolling
Updated: 10/11/2017
Pediatric Endocrinology of Phoenix
mi
from
Phoenix, AZ
Click here to add this to my saved trials
Versartis Long-Acting Growth Hormone in Children Compared to Daily rhGH
Comparison of Somavaratan (VRS-317), a Long-acting Human Growth Hormone, to Daily rhGH in a Phase 3, Randomized, One-year, Open-label, Multi-center, Non-inferiority Trial in Pre-pubertal Children With Growth Hormone Deficiency.
Status: Enrolling
Updated:  10/11/2017
Sierra Medical Research
mi
from
Clovis, CA
Versartis Long-Acting Growth Hormone in Children Compared to Daily rhGH
Comparison of Somavaratan (VRS-317), a Long-acting Human Growth Hormone, to Daily rhGH in a Phase 3, Randomized, One-year, Open-label, Multi-center, Non-inferiority Trial in Pre-pubertal Children With Growth Hormone Deficiency.
Status: Enrolling
Updated: 10/11/2017
Sierra Medical Research
mi
from
Clovis, CA
Click here to add this to my saved trials
Versartis Long-Acting Growth Hormone in Children Compared to Daily rhGH
Comparison of Somavaratan (VRS-317), a Long-acting Human Growth Hormone, to Daily rhGH in a Phase 3, Randomized, One-year, Open-label, Multi-center, Non-inferiority Trial in Pre-pubertal Children With Growth Hormone Deficiency.
Status: Enrolling
Updated:  10/11/2017
Childrens Hospital Los Angeles
mi
from
Los Angeles, CA
Versartis Long-Acting Growth Hormone in Children Compared to Daily rhGH
Comparison of Somavaratan (VRS-317), a Long-acting Human Growth Hormone, to Daily rhGH in a Phase 3, Randomized, One-year, Open-label, Multi-center, Non-inferiority Trial in Pre-pubertal Children With Growth Hormone Deficiency.
Status: Enrolling
Updated: 10/11/2017
Childrens Hospital Los Angeles
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Versartis Long-Acting Growth Hormone in Children Compared to Daily rhGH
Comparison of Somavaratan (VRS-317), a Long-acting Human Growth Hormone, to Daily rhGH in a Phase 3, Randomized, One-year, Open-label, Multi-center, Non-inferiority Trial in Pre-pubertal Children With Growth Hormone Deficiency.
Status: Enrolling
Updated:  10/11/2017
Rady Children's Hospital - San Diego
mi
from
San Diego, CA
Versartis Long-Acting Growth Hormone in Children Compared to Daily rhGH
Comparison of Somavaratan (VRS-317), a Long-acting Human Growth Hormone, to Daily rhGH in a Phase 3, Randomized, One-year, Open-label, Multi-center, Non-inferiority Trial in Pre-pubertal Children With Growth Hormone Deficiency.
Status: Enrolling
Updated: 10/11/2017
Rady Children's Hospital - San Diego
mi
from
San Diego, CA
Click here to add this to my saved trials
Versartis Long-Acting Growth Hormone in Children Compared to Daily rhGH
Comparison of Somavaratan (VRS-317), a Long-acting Human Growth Hormone, to Daily rhGH in a Phase 3, Randomized, One-year, Open-label, Multi-center, Non-inferiority Trial in Pre-pubertal Children With Growth Hormone Deficiency.
Status: Enrolling
Updated:  10/11/2017
The Rocky Mountain Pediatric Endocrinology
mi
from
Centennial, CO
Versartis Long-Acting Growth Hormone in Children Compared to Daily rhGH
Comparison of Somavaratan (VRS-317), a Long-acting Human Growth Hormone, to Daily rhGH in a Phase 3, Randomized, One-year, Open-label, Multi-center, Non-inferiority Trial in Pre-pubertal Children With Growth Hormone Deficiency.
Status: Enrolling
Updated: 10/11/2017
The Rocky Mountain Pediatric Endocrinology
mi
from
Centennial, CO
Click here to add this to my saved trials
Versartis Long-Acting Growth Hormone in Children Compared to Daily rhGH
Comparison of Somavaratan (VRS-317), a Long-acting Human Growth Hormone, to Daily rhGH in a Phase 3, Randomized, One-year, Open-label, Multi-center, Non-inferiority Trial in Pre-pubertal Children With Growth Hormone Deficiency.
Status: Enrolling
Updated:  10/11/2017
Nemours Children's Clinic
mi
from
Jacksonville, FL
Versartis Long-Acting Growth Hormone in Children Compared to Daily rhGH
Comparison of Somavaratan (VRS-317), a Long-acting Human Growth Hormone, to Daily rhGH in a Phase 3, Randomized, One-year, Open-label, Multi-center, Non-inferiority Trial in Pre-pubertal Children With Growth Hormone Deficiency.
Status: Enrolling
Updated: 10/11/2017
Nemours Children's Clinic
mi
from
Jacksonville, FL
Click here to add this to my saved trials